Poliovirus Vaccine, Oral
"Poliovirus Vaccine, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
Descriptor ID |
D011055
|
MeSH Number(s) |
D20.215.894.899.623.750
|
Concept/Terms |
Poliovirus Vaccine, Oral- Poliovirus Vaccine, Oral
- Oral Poliovirus Vaccine
- Vaccine, Oral Poliovirus
- Sabin Vaccine
- Vaccine, Sabin
|
Below are MeSH descriptors whose meaning is more general than "Poliovirus Vaccine, Oral".
Below are MeSH descriptors whose meaning is more specific than "Poliovirus Vaccine, Oral".
This graph shows the total number of publications written about "Poliovirus Vaccine, Oral" by people in this website by year, and whether "Poliovirus Vaccine, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 | 2001 | 1 | 0 | 1 | 2004 | 1 | 1 | 2 | 2007 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2017 | 1 | 1 | 2 | 2018 | 1 | 0 | 1 | 2020 | 0 | 1 | 1 | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Poliovirus Vaccine, Oral" by people in Profiles.
-
Franco-Paredes C, Rodriguez-Morales AJ, Henao-Mart?nez AF, Carrasco P, Tuells J. The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era. Lancet Infect Dis. 2022 10; 22(10):1412-1414.
-
Franco-Paredes C, Santos-Preciado JI, Henao-Martinez AF, Rodriguez-Morales AJ, Carrasco P. Preventing paralytic polio caused by vaccine-derived poliovirus type 2. Lancet Infect Dis. 2020 01; 20(1):21-22.
-
Gaensbauer JT, Gast C, Bandyopadhyay AS, O'Ryan M, Saez-Llorens X, Rivera L, Lopez-Medina E, Melgar M, Weldon WC, Oberste MS, R?ttimann R, Clemens R, Asturias EJ. Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame. Clin Infect Dis. 2018 10 30; 67(suppl_1):S57-S65.
-
Bandyopadhyay AS, Asturias EJ, O'Ryan M, Oberste MS, Weldon W, Clemens R, R?ttimann R, Modlin JF, Gast C. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules. Vaccine. 2017 12 19; 35(52):7283-7291.
-
Lopez-Medina E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, Borate BR, Weldon WC, R?ttimann R, Ward J, Clemens R, Asturias EJ. Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America. Vaccine. 2017 06 16; 35(28):3591-3597.
-
Asturias EJ, Bandyopadhyay AS, Self S, Rivera L, Saez-Llorens X, Lopez E, Melgar M, Gaensbauer JT, Weldon WC, Oberste MS, Borate BR, Gast C, Clemens R, Orenstein W, O'Ryan G M, Jimeno J, Clemens SA, Ward J, R?ttimann R. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial. Lancet. 2016 Jul 09; 388(10040):158-69.
-
O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, R?ttimann R, Costa Clemens SA. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study. Lancet Infect Dis. 2015 Nov; 15(11):1273-82.
-
Franco-Paredes C. Poliovirus eradication. Lancet Infect Dis. 2012 Jun; 12(6):432-3.
-
Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M, Chumakov K, Halsey NA. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis. 2007 Sep 01; 196(5):692-8.
-
Worobey M, Santiago ML, Keele BF, Ndjango JB, Joy JB, Labama BL, Dhed'A BD, Rambaut A, Sharp PM, Shaw GM, Hahn BH. Origin of AIDS: contaminated polio vaccine theory refuted. Nature. 2004 Apr 22; 428(6985):820.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|